Meet the Precision
AQ team at the
ESMO Congress 2026

Schedule time to meet our Precision AQ team at the ESMO Congress 2026 in Madrid, Spain on 23-27 October.

Precision AQ partners with biopharma organizations to help oncology innovations move from evidence generation to global adoption. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.

Our integrated teams support pharmaceutical and biotechnology companies across the product lifecycle, delivering strategic expertise in market access, health economics and outcomes research (HEOR), scientific communications, and investor relations to help demonstrate value, engage stakeholders, and accelerate patient access worldwide.

Explore the expertise our team is bringing to ESMO 2026:

• International Access Strategy: Global market access, pricing, evidence generation, and HTA planning.

• HEOR: Evidence generation and value demonstration to support access, adoption, and reimbursement decisions.

• Healthcare Communications: Scientific communications, medical education, publication planning, and stakeholder engagement.

• Investor Relations & External Communications: Strategic communications and investor engagement that help amplify innovation and corporate value.